SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-083225
Filing Date
2024-07-12
Accepted
2024-07-12 16:30:45
Documents
5
Effectiveness Date
2024-07-12

Document Format Files

Seq Description Document Type Size
1 S-8 apvo-2024-s8_-_sip_incre.htm S-8 103448
2 EX-5.1 apvo-ex5_1.htm EX-5.1 21234
3 EX-23.1 apvo-ex23_1.htm EX-23.1 3656
4 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 18001
5 GRAPHIC img57496738_0.jpg GRAPHIC 5454
  Complete submission text file 0000950170-24-083225.txt   155044
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280789 | Film No.: 241114882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)